GS
GILEAD SCIENCES, INC.
FOSTER CITY CA · SEC CIK 0000882095
$1.65B2026Q2 reported value
5Positions
100.0%Top 10 weight · largest 58.8%
0 / 1New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
ASMB Added+$12.96M
2026Q2 top sells estimated at quarter-end value
Arcellx Inc Sold out-$771.68M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| RCUS | Arcus Biosciences Inc. | $968.83M | 58.76% | 31,424,760 | 0 | 0.0% | — | Unchanged |
| LKFT | Lakefront Biotherapeutics | $500.16M | 30.34% | 16,707,477 | 0 | 0.0% | — | Unchanged |
| ASMB | Assembly Biosciences Inc. | $136.77M | 8.30% | 4,977,089 | 471,698 | 10.5% | $12.96M | Added |
| KYTX | Kyverna Therapeutics Inc. | $36.76M | 2.23% | 4,126,119 | 0 | 0.0% | — | Unchanged |
| — | Xilio Therapeutics Inc. | $6.23M | 0.38% | 650,389 | 0 | 0.0% | — | Unchanged |
| — | Arcellx Inc | $0 | 0.00% | 0 | -6,720,803 | -100.0% | -$771.68M | Sold out |